首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Journal of alzheimers disease reports

缩写:

ISSN:N/A

e-ISSN:2542-4823

IF/分区:2.8/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引682
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Richard Lathe,Brian Balin Richard Lathe
We draw attention to a historic case of a boy who suffered from scarlet fever (typically caused by the bacterium Streptococcus pyogenes) at age 7 years and went on to develop the symptoms of Alzheimer's disease (AD). His physicians believed...
Rajesh Ranganathan,Siwen Li,Georgy Sapozhnikov et al. Rajesh Ranganathan et al.
Background: Neurons in Alzheimer's disease (AD) experience elevated DNA damage, with DNA repair sites enriched at enhancer regions of genes essential for neuronal survival. Excitatory neurons in the cortical superficial l...
William B Grant William B Grant
Background: Diet plays an important role in the risk of Alzheimer's disease (AD) and dementia. Adherence to the Mediterranean diet is regarded as one way to reduce risk. Fish is a component of the Mediterranean diet. Part...
Yuhang Chen,Junlin Diao,Xuezhuang Ren et al. Yuhang Chen et al.
Background: Cognitive impairment patients are prone to malnutrition, which further promotes cognitive decline. Cognitive impairment patients are unable to accurately answer subjective questions in the nutrition screening ...
Boyang Su,Zhengqing He,Li Mao et al. Boyang Su et al.
Background: Increasing evidence suggests that abnormal lipid metabolism is one of the pathogeneses of dementia. It is necessary to reveal the relationship between lipids and dementia. ...
Antonio Valle-Medina,Claudia Camelia Calzada-Mendoza,María Esther Ocharan-Hernández et al. Antonio Valle-Medina et al.
Alzheimer's disease (AD) is considered a global health issue with a high social burden due to the level of disability it causes in those who suffer from it. In the absence of a therapeutic alternative for this disease, we will follow one of...
Kenichiro Sato,Yoshiki Niimi,Ryoko Ihara et al. Kenichiro Sato et al.
Lecanemab, an anti-amyloid therapy for early Alzheimer's disease, received approval by the FDA and Japan in 2023. Public response on social media was scrutinized, aiming to obtain insights into communication and treatment development. For 4...
Xiaohang Zhang,Wenze Wu,Yaqing Mao et al. Xiaohang Zhang et al.
Background: Previous observational studies demonstrated a link existed between traumatic brain injury (TBI) and cerebral disease and multisystem complications, such as dementia, pneumonia, and gastrointestinal disease, bu...
Yan-Siang Huang,Te-Jung Kung,Yi-Fang Chuang Yan-Siang Huang
Background: Intravenous thrombolysis (IVT) is the standard treatment for acute ischemic stroke (AIS) to improve functional outcomes. Furthermore, AIS is an important risk factor for dementia. Limited evidence has shown th...